Viewing Study NCT00512902


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-03-04 @ 11:54 PM
Study NCT ID: NCT00512902
Status: COMPLETED
Last Update Posted: 2014-10-27
First Post: 2007-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
Sponsor: University of California, Los Angeles
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alveolitis View
None Systemic Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None active alveolitis in systemic sclerosis View